Early experience with a new approach for percutaneous intervention of totally occluded saphenous vein graft: is the flow the best thrombolytic?

AIMS Percutaneous coronary intervention (PCI) in the total occlusion of aged saphenous vein grafts (SVGO) is difficult because of inadequate dilatation and distal embolisation. The aim of this study is to report the early experience and clinical outcome of SVGO PCI with a multistaged procedure. METHODS AND RESULTS Between January 2003-2006, we treated 20 consecutive patients (pts) admitted with the diagnosis of non-ST segment elevation acute coronary syndromes with culprit lesion located in SVGO. All of them underwent a three stage procedure. Stage 1: recanalisation of graft with undersized balloon; Stage 2: anticoagulation therapy; Stage 3: treatment according to the angiographic result. We obtained vessel recanalisation with TIMI flow 1-2 in 14 pts (70%) by undersized balloon (mean diameter of 1,85±0,43 mm). The mean anticoagulation time was 11±7 days (range 1-20 days). At the Stage 3 all 14 SVG (100%) were patent. A focal lesion was present in 12 pts (86%) treated by stent implantation. In the other two pts (14%) the SVG had no residual lesion. The in-hospital major adverse cardiac event rate was 10%. No death, in-hospital late closure or major bleeding complication occurred. At 2-year follow-up one target vessel revascularisation and one in stent restenosis occurred. CONCLUSIONS The treatment of SVGO with staged procedure may be used to decrease thrombus burden prior to definitive "short" stent placement and improve the acute and long-term results.

[1]  William Wijns,et al.  [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes]. , 2007, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[2]  G. Stone,et al.  Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era. , 2008, The American journal of cardiology.

[3]  J. Alpert,et al.  Universal definition of myocardial infarction. , 2007, European heart journal.

[4]  P. Serruys,et al.  Chronic total occlusion treatment in post‐CABG patients: Saphenous vein graft versus native vessel recanalization—Long‐term follow‐up in the drug‐eluting stent era , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[5]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[6]  Antonio Colombo,et al.  [Guidelines for percutaneous coronary interventions]. , 2005, Revista espanola de cardiologia.

[7]  Antonio Colombo,et al.  Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. , 2005, European heart journal.

[8]  M. Mittlböck,et al.  EuroSCORE predicts mid-term outcome after combined valve and coronary bypass surgery. , 2004, The Journal of heart valve disease.

[9]  M. Schalij,et al.  Randomized study to compare balloon angioplasty and elective stent implantation in venous bypass grafts: The Venestent Study , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[10]  E. Falk,et al.  Pathology of coronary microembolisation and no reflow , 2003, Heart.

[11]  P. Feyter Percutaneous Treatment of Saphenous Vein Bypass Graft Obstructions A Continuing Obstinate Problem , 2003 .

[12]  P. D. de Feyter Percutaneous treatment of saphenous vein bypass graft obstructions: a continuing obstinate problem. , 2003, Circulation.

[13]  E. Braunwald,et al.  A classification of unstable angina revisited. , 2000, Circulation.

[14]  R. Erbel,et al.  Percutaneous transluminal therapy of occluded saphenous vein grafts: can the challenge be met with ultrasound thrombolysis? , 1999, Circulation.

[15]  M. Bell,et al.  Influence of procedural success on immediate and long-term clinical outcome of patients undergoing percutaneous revascularization of occluded coronary artery bypass vein grafts. , 1996, Journal of the American College of Cardiology.

[16]  W. O’Neill,et al.  Recanalization of Chronically Occluded Aortocoronary Saphenous Vein Bypass Grafts With Long-Term, Low Dose Direct Infusion of Urokinase (ROBUST): a serial trial. , 1996, Journal of the American College of Cardiology.

[17]  R. Califf,et al.  Predictors and sequelae of distal embolization during saphenous vein graft intervention from the CAVEAT-II trial. Coronary Angioplasty Versus Excisional Atherectomy Trial. , 1995, Circulation.

[18]  E. Topol,et al.  Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. , 1993, Journal of the American College of Cardiology.

[19]  R Roberts,et al.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. , 1987, Circulation.